NovaBridge Biosciences NBP
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each CNY of equity lost 21 cents this year.
The 9-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue CNY B | ◌ | ◌ | ◌ | ◌ | 0.1 | 1.5 | 0.0 | 0.1 | 0.0 |
| Operating income CNY B | ◌ | ◌ | ◌ | ◌ | −2.3 | 0.5 | −1.5 | −0.4 | −0.3 |
| EBITDA CNY B | −0.1 | −0.1 | −0.1 | −0.1 | −2.3 | 0.5 | −1.4 | −0.4 | −0.3 |
| Income tax CNY B | ◌ | ◌ | ◌ | ◌ | −0.0 | 0.0 | 0.0 | 0.0 | ◌ |
| Net income CNY B | ◌ | ◌ | ◌ | ◌ | −2.3 | 0.5 | −1.5 | −0.4 | −0.3 |
| Free cash flow CNY B | −0.0 | −0.1 | −0.1 | −0.1 | −1.0 | 0.4 | −0.9 | −0.3 | −0.3 |
| EPS, diluted CNY | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | −51.93 |
| Dividend / sh CNY | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — |
| ROE % | −21.4 | −10.0 | −62.9 | −65.5 | ◌ | — | — | — | — |
| Shares out B | 0.27 | 0.19 | 0.19 | 0.19 | 0.18 | 0.16 | 0.01 | 0.01 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 4 of the 9 fiscal years we could check. 22 checks were skipped: the balance sheet is not tagged before 2018. 12 checks were skipped: cost of revenue is not tagged before 2019. 10 checks were skipped: EPS is not tagged before 2017.